The Patent Finder

Delmar Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Delmar Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.

Showing 1 to 7 of 7 · Back to Delmar Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,446,274Use of Dianhydrogalactitol or Derivatives or Analogs Thereof for Treatment of Pediatric Central Nervous System Malignancies
Lapsed on the fee record
Ended Sep 20, 2026 · High confidence
Lapsed on the fee recordEnded Sep 20, 2026High confidence
US 9,901,563Compositions to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
Lapsed on the fee record
Ended Feb 27, 2026 · USPTO record
Lapsed on the fee recordEnded Feb 27, 2026USPTO record
US 9,814,693Veterinary use of dianhydrogalactitol, diacetyldianhydrogalactitol, and dibromodulcitol to treat malignancies
Lapsed on the fee record
Ended Nov 14, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 14, 2025USPTO record
US 8,563,758Method of synthesis of substituted hexitols such as dianhydrogalactitol
Lapsed on the fee record
Ended Oct 22, 2025 · USPTO record
Lapsed on the fee recordEnded Oct 22, 2025USPTO record
US 9,759,698Analytical methods for analyzing and determining impurities in dianhydrogalactitol
Lapsed on the fee record
Ended Sep 12, 2025 · USPTO record
Lapsed on the fee recordEnded Sep 12, 2025USPTO record
US 9,687,466Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme
Lapsed on the fee record
Ended Jun 27, 2025 · USPTO record
Lapsed on the fee recordEnded Jun 27, 2025USPTO record
US 9,630,938Method of synthesis of substituted hexitols such as dianhydrogalactitol
Lapsed on the fee record
Ended Apr 25, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 25, 2025USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited